Use of il-27 agonists to reduce immune mediated abortion

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/17 (2006.01) A61K 38/20 (2006.01) A61P 15/06 (2006.01)

Patent

CA 2671697

Provided are cytokines and methods of modulating maternal tolerance of a fetus using IL-27 agonists. Also provided are methods of modulating implantation of an embryo to a uterine lining, and methods of diagnosis.

L'invention concerne des cytokines et des procédés de modulation de la tolérance maternelle d'un fAEtus qui utilisent des agonistes d'IL-27. L'invention concerne également des procédés de modulation de l'implantation d'un embryon sur la paroi utérine, et des procédés de diagnostic.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of il-27 agonists to reduce immune mediated abortion does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of il-27 agonists to reduce immune mediated abortion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of il-27 agonists to reduce immune mediated abortion will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1937896

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.